Identification of NMU as a potential gene conferring alectinib resistance in non-small cell lung cancer based on

Shuangjie You1, Lei Gao1

  • 1Department of Heart Failure, Research Center for Translational Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.

Gene
|August 11, 2018
PubMed

Insights

Neuromedin U (NMU) may cause resistance to alectinib, a targeted therapy for non-small cell lung cancer (NSCLC). This discovery, based on bioinformatics, offers insights into overcoming treatment challenges in NSCLC patients with ALK-rearrangements.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • Non-small cell lung cancer (NSCLC) is a prevalent malignancy.
  • Targeted therapies like alectinib offer benefits for NSCLC patients with specific genomic alterations, such as anaplastic lymphoma kinase (ALK) rearrangements.
  • Therapeutic resistance to alectinib is a significant clinical challenge, limiting treatment efficacy.

Purpose of the Study:

  • To identify potential mechanisms contributing to alectinib resistance in NSCLC.
  • To investigate the role of neuromedin U (NMU) in conferring resistance to alectinib treatment.
  • To explore NMU as a therapeutic target for overcoming alectinib resistance.

Main Methods:

  • Integrative bioinformatics analysis of three microarray datasets.
  • Identification of NMU as a candidate gene overexpressed in NSCLC and alectinib-resistant cells.
  • Validation through protein/gene interaction analysis, biological process annotation, and transcription factor analysis.

Main Results:

  • Neuromedin U (NMU) was identified as significantly overexpressed in both NSCLC tissues and alectinib-resistant NSCLC cell lines.
  • Bioinformatics analyses supported NMU's role in conferring alectinib resistance through multiple mechanisms.
  • Further analysis confirmed the involvement of transcription factors regulating NMU mRNA expression.

Conclusions:

  • Neuromedin U (NMU) is implicated as a key factor in the development of alectinib resistance in non-small cell lung cancer.
  • Targeting NMU may represent a novel therapeutic strategy to overcome alectinib resistance in NSCLC patients with ALK-rearrangements.
  • These findings provide a basis for further experimental validation and clinical investigation.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Gene Flow02:39

Gene Flow

Gene flow is the transfer of genes among populations, resulting from either the dispersal of gametes or from the migration of individuals.
38.0K
Cell Potential and Free Energy02:58

Cell Potential and Free Energy

Thermodynamics of a Redox Reaction
Thermodynamics is the branch of physics dealing with the relationship between heat and other forms of energy. In an electrochemical cell, chemical energy is converted into electrical energy.
Thus, a link can be predicted between cell potential, free energy change, and the equilibrium constant for the reaction. Cell potential can also be measured as the oxidant or the reducing strength, and similar acid-base strength measures are reflected in equilibrium...
46.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.8K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.5K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.6K